antisense oligomer (La Jolla/University College Cork)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantisense oligomer (La Jolla/University College Cork)
Drug Alias NameBcr-abl antisense oligomer (La Jolla/University College Cork)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionBcr-Abl tyrosine kinase modulators
TargetsBcr-Abl tyrosine kinase
Therapy Area/IndicationsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIreland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLa Jolla Institute For Allergy & Immunology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLa Jolla Institute For Allergy & ImmunologyUniversity College Cork
Active IndicationsN/A
Inactive IndicationsLeukemia, Myelogenous, Chronic

Other Information

ATC CodeN/A
Related LinksN/A